Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 20:44:38 GMT 2025
by
admin
on
Mon Mar 31 20:44:38 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
WGD229O42W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
TENECTEPLASE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
||
|
NCI_THESAURUS |
C29750
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
METALYSE (AUTHORIZED:MYOCARDIAL INFARCTION)
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
||
|
WHO-ATC |
B01AD11
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
||
|
WHO-VATC |
QB01AD11
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
||
|
FDA ORPHAN DRUG |
276709
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
JJ-85
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | |||
|
191588-94-0
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | |||
|
5066
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | |||
|
C29489
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | |||
|
100000085233
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | |||
|
7769
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | |||
|
m10556
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | Merck Index | ||
|
WGD229O42W
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | |||
|
C121182
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | |||
|
DB00031
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | |||
|
SUB04718MIG
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | |||
|
TENECTEPLASE
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | |||
|
CHEMBL2108791
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | |||
|
259280
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY | RxNorm | ||
|
WGD229O42W
Created by
admin on Mon Mar 31 20:44:38 GMT 2025 , Edited by admin on Mon Mar 31 20:44:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SUBSTRATE->ENZYME |
|
||
|
TARGET->ENZYME |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|